Log in to save to my catalogue

Treatment of chronic hepatitis C-associated cryoglobulinemia vasculitis at the era of direct-acting...

Treatment of chronic hepatitis C-associated cryoglobulinemia vasculitis at the era of direct-acting...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a091dd2781a347ef897729cd6307d588

Treatment of chronic hepatitis C-associated cryoglobulinemia vasculitis at the era of direct-acting antivirals

About this item

Full title

Treatment of chronic hepatitis C-associated cryoglobulinemia vasculitis at the era of direct-acting antivirals

Publisher

London, England: SAGE Publications

Journal title

Therapeutic Advances in Gastroenterology, 2020, Vol.13, p.1756284820942617-1756284820942617

Language

English

Formats

Publication information

Publisher

London, England: SAGE Publications

More information

Scope and Contents

Contents

Hepatitis C virus (HCV) infection is responsible for both hepatic and extrahepatic manifestations. Before the era of direct-acting antivirals (DAA), cryoglobulinemia was related to HCV infection in 70–90% of cases. Observed in 30% to 40% of patients with hepatitis C, mixed cryoglobulinemia is mainly asymptomatic. Conversely, symptomatic cryoglobuli...

Alternative Titles

Full title

Treatment of chronic hepatitis C-associated cryoglobulinemia vasculitis at the era of direct-acting antivirals

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_a091dd2781a347ef897729cd6307d588

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a091dd2781a347ef897729cd6307d588

Other Identifiers

ISSN

1756-2848,1756-283X

E-ISSN

1756-2848

DOI

10.1177/1756284820942617

How to access this item